In just a few weeks, I will be announcing the recipient(s) of the 4th Annual Pharmaguy Social Pioneer Award at the Digital Pharma East conference in Philadelphia. s part of the ceremony, I will pass on the famous -- or infamous, depending...Show More Summary
A few months ago, I engaged Peter Houston (@Flipping_Pages) in a discussion about whether or not pharma "should" do Tumblr, a social media site that allows users to post text, photos, quotes, links, music, and videos from browsers, phones, via email or wherever (see "Should Pharma Do Tumblr?"). Show More Summary
Science Weekly Extra: An extended interview with Ben Goldacre on Bad Pharma http://audio.theguardian.tv/audio/kip/science/series/science/1350653685662/7287/gnl.sci.120122.jp.science_weekly_goldacrefull.mp3 In Science Extra this weekShow More Summary
The issue of drug shortages has surfaced periodically in the news and in policy circles for months, prompting both FDA and the Administration to various actions. For some, it may be an abstract notion – the idea that some drugs … Continue reading ?
As if hearing my voice on the page isn't enough, here's a podcast I did last week with Paul Howard of the Manhattan Institute on the FDA's Avastin decision. You might think that they'd be all worked up about this (a la the Wall Street Journal's editorial page), but you might be surprised...
The past two days have been focused on The Physician Payment Sunshine provisions of the Patient Protection Affordable Care Act in the U.S. which will require the reporting of financial relationships between medical product manufacturers and medical providers by 2013. … Continue reading ?
Here's an interview that I did recently with Paul Howard of the Manhattan Institute on the results of that immunotherapy leukemia trial (and on some broader topics around the current state of drug discovery). Anyone who would like to...Show More Summary
It is another one of those questions – how did we get here? For months FDA’s DDMAC did not seem to understand the impact of social media, then asked for help understanding how to regulate it, then failed to produce … Continue readi...
23 May 2011 The need for new ways to define disease listen now | download audio In a series of articles in the British Medical Journal Australian medical journalist Ray Moynihan argues that there are problems in the way diseases are defined. Show More Summary
Last Friday, the FDA published notice about draft guidance on the issue of menu labeling in restaurants. The idea of labeling food choices in restaurants has long been a goal of those who advocate for greater education for consumers in … Continue reading ?
The $100 Spike guys, Gage and Marzullo, are back at the SfN annual meeting this year with additional developments. If you missed out, a version of their 2008 presentation is available here and it will give you a bit of the flavor. There...Show More Summary
Apparently the $100 spike boyz have been busy bees over the past year. To recap: As I stumbled back deep into the UU section (the end) of the afternoon SfN poster session in search of coffee, I noticed a bit of a crowd surrounding a poster board, in rapt attention. Show More Summary
Eli Lilly, the drug company, is expected to agree as soon as Thursday to pay $1.4 billion to settle criminal and civil charges that it illegally marketed its blockbuster antipsychotic drug Zyprexa for unauthorized use in patients particularly...Show More Summary
Remember the $100 Spike project from this year's SfN meeting? One of the project authors noted on his blog Marzullo Head that Nature's Neuropod posted a podcast on the SfN meeting which included a segment on the $100 Spike. Read the comments on this post...
Speaking of prof-blogging, I've had the pleasure of two additional excellent commentaries on blogging issues this week. I think many people referenced John Hawks' first piece on using blogging as part of one's dossier for tenure. What...Show More Summary